A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma

ConclusionHypofractionated neoadjuvant chemoradiation is associated with reduced systemic loss of T cells.Trial registrationClinicalTrials.govNCT01342224, April 21, 2011;NCT01903083, July 2, 2013.

http://link.springer.com/10.1186/s40425-016-0149-6

Source: Journal for Immunotherapy of Cancer - August 15, 2016 Category: Cancer & Oncology Source Type: research